Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NSCLC)

NCT00088088 is registered in ClinicalTrials.gov with Synta Pharmaceuticals Corp. as lead sponsor.

NCT NCT00088088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00088088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Synta Pharmaceuticals Corp.
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2004
Completion date
March 31, 2005
Enrollment
86
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer